Navigation Links
GlaxoSmithKline Aids California Fire Relief Efforts
Date:10/26/2007

Donations of more than $1 million worth of prescription medicines and

consumer products offered

RESEARCH TRIANGLE PARK, N.C., Oct. 26 /PRNewswire/ -- GlaxoSmithKline (NYSE: GSK) shares the nation's concern for residents and communities of California's San Diego region that are being ravaged by widespread fires. As a demonstration of support, GSK has offered to the people impacted more than $1 million dollars worth of respiratory medicines and $100,000 worth of consumer products, including Aquafresh products and Tums.

"GSK is committed to helping the relief effort by providing the State of California and its state-based, disaster-response organizations with medicines and other healthcare products that are needed by those whose lives have been turned upside down by this tragedy," said Christopher Viehbacher, President, US Pharmaceuticals, GlaxoSmithKline.

GSK has already shipped $300,000 worth of asthma medicine to Direct Relief International, a Santa Barbara-based relief organization with expertise in fast delivery of medicines in times of disaster. Direct Relief's close proximity to the regions affected by the fires means they have been able to provide immediate emergency relief to those in need.

GSK has also reached out to other relief organizations - AmeriCares, MAP International, Project HOPE and Interchurch (IMA) - to assess the ongoing needs of residents and communities throughout San Diego county. If these organizations ask for additional medicines, GSK will seek to fulfill the requests.

GSK is also helping its employees and their families based in the San Diego region recover from the fires. A disaster relief fund is available to provide employees with up to $5,000 grants to cover emergency needs, such as temporary housing, food and transportation.

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.


'/>"/>
SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
2. GlaxoSmithKline To Cultivate Non-Smoking Environment
3. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
4. FDA Mislead On Asthma Drug By GlaxoSmithKline
5. GlaxoSmithKline Defends Its Products
6. GlaxoSmithKline launches diabetes and cancer drugs
7. Generic Products Compete With GlaxoSmithKline
8. GlaxoSmithKline Agrees To Settle Paxil Claims For $14 million
9. GlaxoSmithKlines Zofran Helps In Treatment Of Dehydration In Children
10. Ranbaxy Acquires Glaxosmithklines Generic Unit in Spain
11. GlaxoSmithKline’s Epilepsy Drug given the Green Signal by FD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Neurotechnology , a provider ... and attendance tracking products: the new NCheck Cloud Bio Attendance cloud-based service and ... biometric face recognition to enable users to check in and out from anywhere ...
(Date:3/28/2017)... ... March 28, 2017 , ... METTLER TOLEDO Process ... in power plant water and steam. , Chlorides and sulfates cause pitting and ... to extensive maintenance and unplanned shutdowns. Monitoring these ions at low ppb levels ...
(Date:3/28/2017)... Florida (PRWEB) , ... March 28, 2017 , ... The ... Corp to raise money to for the Toys for Tots Literacy Campaign at their ... budget in excess of $70 billion, the U.S. ranks at number 14 internationally in ...
(Date:3/28/2017)... ... , ... A minimally invasive porcelain veneer is increasing in ... of Dental Laboratories (NADL) is informing dentists about the benefits of minimally invasive ... laboratories and technicians that create these veneers. , According to National Board ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... Liu of SkyLex Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved ... procedure, and this procedure adds to SkyLex Advanced Surgical’s already comprehensive list ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... VICTORIA and TORONTO , ... Canada,s leading full service medical device development ... Group, the visionary Toronto -based medical ... entity will better serve medtech companies throughout ... increased resources and experienced medical device talent spanning the ...
(Date:3/28/2017)... and TEL AVIV, Israel , March 28, ... in Israel . This new business entity, Emosis ... mostly dedicated to research and development of novel assays complementing the ... also, when relevant, locally support commercialization and sales development of Emosis ... This strategic ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
Breaking Medicine Technology: